|Summary||This e-learning module has been developed in collaboration with European Insititute of Oncology Education.|
This e-learning module aims to educate medical practitioners on the latest emerging evidence in the optimal integration of anti-angiogenic therapy in the treatment plan for gastric cancer patients which can then be applied in clinical practice. The information in this module is based on information presented at the Angiogenesis: Latest Developments in Gastric Cancer event at 25th March, 2015 in Milan, Italy.
This module is for medical practitioners with an interest in gastric cancer.
By the end of the module, you should be able to:
• Understand the mechanisms and biology behind angiogenesis.
The date of preparation for this module is 25th March, 2015. This module takes approximately one hour to complete.
This module awards 1 CME point upon passing post-module assessment.
This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.
If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.
If you are experiencing technical difficulties, please contact firstname.lastname@example.org and we will get back to you as soon as possible.
ecancer and Prof Gordon McVie have no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible with support from Lilly Oncology and Beckman Coulter Life Sciences.